BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23341329)

  • 21. Impact of sentinel node status and other risk factors on the clinical outcome of head and neck melanoma patients.
    Leong SP; Accortt NA; Essner R; Ross M; Gershenwald JE; Pockaj B; Hoekstra HJ; Garberoglio C; White RL; Chu D; Biel M; Charney K; Wanebo H; Avisar E; Vetto J; Soong SJ;
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):370-3. PubMed ID: 16618904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma.
    Lavaf A; Genden EM; Cesaretti JA; Packer S; Kao J
    Cancer; 2008 Feb; 112(3):535-43. PubMed ID: 18076014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical relevance of three subtypes of primary sinonasal lymphoma characterized by immunophenotypic analysis.
    Kim GE; Koom WS; Yang WI; Lee SW; Keum KC; Lee CG; Suh CO; Hahn JS; Roh JK; Kim JH
    Head Neck; 2004 Jul; 26(7):584-93. PubMed ID: 15229900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cutaneous B-cell lymphoma prognostic index: a novel prognostic index derived from a population-based registry.
    Smith BD; Smith GL; Cooper DL; Wilson LD
    J Clin Oncol; 2005 May; 23(15):3390-5. PubMed ID: 15908651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin.
    López-Guillermo A; Colomo L; Jiménez M; Bosch F; Villamor N; Arenillas L; Muntañola A; Montoto S; Giné E; Colomer D; Beà S; Campo E; Montserrat E
    J Clin Oncol; 2005 Apr; 23(12):2797-804. PubMed ID: 15728226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome following Reduced-Intensity Allogeneic Stem Cell Transplantation (RIC AlloSCT) for relapsed and refractory mantle cell lymphoma (MCL): a study of the British Society for Blood and Marrow Transplantation.
    Cook G; Smith GM; Kirkland K; Lee J; Pearce R; Thomson K; Morris E; Orchard K; Rule S; Russell N; Craddock C; Marks DI;
    Biol Blood Marrow Transplant; 2010 Oct; 16(10):1419-27. PubMed ID: 20399879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary pancreatic lymphoma: a population-based analysis using the SEER program.
    Mishra MV; Keith SW; Shen X; Bar Ad V; Champ CE; Biswas T
    Am J Clin Oncol; 2013 Feb; 36(1):38-43. PubMed ID: 22134518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival outcomes for head and neck squamous cell carcinoma arising after lymphoma.
    Moore MG; Bhattacharyya N
    Otolaryngol Head Neck Surg; 2008 Mar; 138(3):388-93. PubMed ID: 18312890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management Trends and Outcomes for Stage I to II Mantle Cell Lymphoma Using the National Cancer Data Base: Ascertaining the Ideal Treatment Paradigm.
    Gill BS; Vargo JA; Pai SS; Balasubramani GK; Beriwal S
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):668-76. PubMed ID: 26461009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Five-year survival does not equal cure in non-small cell lung cancer: a Surveillance, Epidemiology, and End Results-based analysis of variables affecting 10- to 18-year survival.
    Hubbard MO; Fu P; Margevicius S; Dowlati A; Linden PA
    J Thorac Cardiovasc Surg; 2012 Jun; 143(6):1307-13. PubMed ID: 22361247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of adenoid cystic carcinoma in nova scotia: 30-year population-based epidemiologic study.
    Bonaparte JP; Hart R; Trites J; Taylor MS
    J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):642-8. PubMed ID: 19128670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of external beam radiotherapy is associated with reduced incidence of second primary head and neck cancer: a SEER database analysis.
    Rusthoven K; Chen C; Raben D; Kavanagh B
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):192-8. PubMed ID: 18078720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultrathin primary is a marker for worse prognosis in lymph node-positive cutaneous melanoma.
    Bagaria SP; Ray PS; Joseph RW; Heckman MG; Rawal B; Gray RJ; Pockaj B; Wasif N
    Cancer; 2013 May; 119(10):1860-7. PubMed ID: 23408288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of radiotherapy on the survival of patients with stage I and stage II mantle cell lymphoma: analysis of the Surveillance, Epidemiology and End Results database.
    Guru Murthy GS; Venkitachalam R; Mehta P
    Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl():S90-5. PubMed ID: 25486963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
    Di Saverio S; Gutierrez J; Avisar E
    Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastrointestinal follicular lymphoma: using primary site as a predictor of survival.
    Chouhan J; Batra S; Gupta R; Guha S
    Cancer Med; 2016 Oct; 5(10):2669-2677. PubMed ID: 27696758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Initial clinical findings of a mathematical model to predict survival of head and neck cancer.
    Emerick KS; Leavitt ER; Michaelson JS; Diephuis B; Clark JR; Deschler DG
    Otolaryngol Head Neck Surg; 2013 Oct; 149(4):572-8. PubMed ID: 23797612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignant pheochromocytoma and paraganglioma: a population level analysis of long-term survival over two decades.
    Goffredo P; Sosa JA; Roman SA
    J Surg Oncol; 2013 May; 107(6):659-64. PubMed ID: 23233320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network.
    Tiemann M; Schrader C; Klapper W; Dreyling MH; Campo E; Norton A; Berger F; Kluin P; Ott G; Pileri S; Pedrinis E; Feller AC; Merz H; Janssen D; Hansmann ML; Krieken H; Möller P; Stein H; Unterhalt M; Hiddemann W; Parwaresch R;
    Br J Haematol; 2005 Oct; 131(1):29-38. PubMed ID: 16173960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of the head and neck.
    Argiris A; Li Y; Forastiere A
    Cancer; 2004 Nov; 101(10):2222-9. PubMed ID: 15452834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.